Participated · Seed · Jun 2026

Joyvié Health has developed continence underwear designed to contain stool in a disposable pouch immediately after excretion, which the company says significantly reduces stool-to-skin contact and speeds changes. Early testing reported approximately a 90% reduction in stool-to-skin contact and roughly 70% faster change times. The company frames its product as addressing faecal incontinence, a condition estimated to affect 656 million people globally and often linked to cancer, dementia, MS, Parkinson’s, spinal injury or ageing. Joyvié was founded by Zoe Robson after a family caregiving experience in 2025 and intends to run pilots across care homes, hospitals and domiciliary settings to collect clinical and health-economics data. Planned near-term activities include a direct-to-consumer launch later this year, publishing white papers, forming strategic partnerships and making first hires. The company also highlights disparities in funding for women’s health and female founders as part of its market-context narrative.

Participated · Seed · Aug 2025

EnsiliTech’s patented Ensilication technology applies tiny inorganic silica layers to individual biological molecules, creating protective cages that keep vaccines, antibodies and other biopharmaceuticals stable outside the cold chain and able to withstand temperatures up to 50°C. The silica coating is biocompatible, inert and inexpensive; when a product is ready for use the cage breaks away leaving the active ingredient intact. The company positions this platform as a way to eliminate expensive, energy-intensive refrigeration in transport and storage, reduce drug waste and broaden access—particularly in regions where reliable cold-chain infrastructure is lacking. EnsiliTech reports early technical efficacy, in vivo safety validation and live commercial negotiations with billion-euro pharma partners, indicating growing commercial momentum. The team is predominantly female-led across leadership and R&D, an attribute that attracted investors focused on female-led businesses. The recent financing will support expansion of capacity, new hires, upgraded infrastructure and critical validation studies to embed Ensilication into pharmaceutical manufacturing processes. EnsiliTech has developed a patented platform technology called ensilication that can be applied to existing and new biopharmaceuticals to make them safe and stable at room temperatures. The technology preserves the integrity of vaccines and other biological materials across a wide temperature range (−20°C to +80°C). The company intends to use recently raised funds to develop a refrigeration-free approach to transporting vaccines and other materials. Ensilication aims to improve vaccine and biological-material distribution in developing countries where reliable refrigeration is a barrier to healthcare. The platform could also enable more rapid and safe distribution of Covid-19 vaccines to communities in need. EnsiliTech is led by Co‑founder and CEO Dr. Asel Sartbaeva and CTO Dr. Aswin Doekhie.

Participated · Seed · May 2023

Deployed offers a collaborative platform that simplifies writing, editing and publishing Statements of Work for change, procurement, finance, legal, HR and compliance projects. The platform brings multiple stakeholders together in a single place to streamline SOW creation and collaboration. The company serves enterprise clients including Talent Solutions TAPFIN, Randstad Sourceright and Roche. Co-founded by Emma Rees (CEO), Kayleigh Kuptz (COO) and Jamie Gannaway (CPO), Deployed plans to further develop product features and apply assisted writing and generative AI. The company intends to use the new funding to expand new and existing enterprise clients and to increase hiring.

Participated · Seed · May 2022

Flexa Careers is a London-based platform that enables companies to showcase and verify their working policies, flexibility, and benefits so candidates can see how organisations operate before applying. The product uses a two-stage benchmarking process that reviews company approaches to location and benefits and surveys employees about their experience. Founded in early 2020, the service has been used by candidates across 70 countries, with a core audience in the UK and Ireland. The company reports over 450,000 users and more than 150 approved companies headquartered worldwide. Flexa plans to use its new funding to expand its global reach and continue growing its verified employer marketplace. Flexa operates a job listings platform that accepts ads only from employers who allow flexible working arrangements. The platform lists jobs exclusively from employers offering flexible-work options. The company is described as a tech start-up in the articles. The coverage reports that Flexa raised €250k in funding from investors. The articles do not provide investor names, funding instrument details, or additional operational and financial metrics.